Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-09-20
2010-10-12
Saunders, David A (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S810000, C530S388730, C530S868000
Reexamination Certificate
active
07811570
ABSTRACT:
Provided are methods and compositions for detecting and treating normal, hypoplastic, ectopic or remnant tissue, organ or cells in a mammal. The method comprises parenterally injecting a mammalian subject, at a locus and by a route providing access to said tissue or organ, with an composition comprising antibody/fragment which specifically binds to targeted organ, tissue or cell. The antibody/fragment may be administered alone, or labeled or conjugated with an imaging, therapeutic, cytoprotective or activating agent.
REFERENCES:
patent: 3683066 (1972-08-01), Ascanio et al.
patent: 3927193 (1975-12-01), Hansen et al.
patent: 4036945 (1977-07-01), Haber
patent: 4087516 (1978-05-01), Laidler et al.
patent: 4234561 (1980-11-01), Bahl
patent: 4348376 (1982-09-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
patent: 4434156 (1984-02-01), Trowbridge
patent: 4440747 (1984-04-01), Neville, Jr. et al.
patent: 4443427 (1984-04-01), Reinherz et al.
patent: 4444744 (1984-04-01), Goldenberg
patent: 4489710 (1984-12-01), Spitler
patent: 4500508 (1985-02-01), Srivastava et al.
patent: 4578335 (1986-03-01), Urdal et al.
patent: 4620971 (1986-11-01), Hou
patent: 4647447 (1987-03-01), Gries et al.
patent: 4693884 (1987-09-01), Kleiner et al.
patent: 4732864 (1988-03-01), Tolman
patent: 4735210 (1988-04-01), Goldenberg
patent: 4857637 (1989-08-01), Hammonds et al.
patent: 4859449 (1989-08-01), Mattes
patent: 5011684 (1991-04-01), Strom
patent: 5091313 (1992-02-01), Chang
patent: 5101827 (1992-04-01), Goldenberg
patent: 5144007 (1992-09-01), Pfahl
patent: 5144010 (1992-09-01), Erlanger et al.
patent: 5152980 (1992-10-01), Strom et al.
patent: 5182368 (1993-01-01), Ledbetter et al.
patent: 5208021 (1993-05-01), Johnson et al.
patent: 5322699 (1994-06-01), Wright et al.
patent: 5326559 (1994-07-01), Miller
patent: 5411985 (1995-05-01), Bills et al.
patent: 5443953 (1995-08-01), Hansen et al.
patent: 5510105 (1996-04-01), Strom
patent: 5670151 (1997-09-01), Larrick et al.
patent: 5697902 (1997-12-01), Goldenberg
patent: 6331175 (2001-12-01), Goldenberg
patent: 6893625 (2005-05-01), Robinson et al.
patent: 7074403 (2006-07-01), Goldenberg et al.
patent: 86 330/82 (1982-07-01), None
patent: B-19579/88 (1988-12-01), None
patent: B-39339/89 (1989-08-01), None
patent: 2072017 (1991-06-01), None
patent: 0 028 092 (1980-10-01), None
patent: 0 035 265 (1981-03-01), None
patent: 0 149 709 (1984-07-01), None
patent: 0 135 125 (1984-08-01), None
patent: 0 208 531 (1986-07-01), None
patent: 0 217 992 (1987-04-01), None
patent: 0 274 394 (1988-07-01), None
patent: 0 330 201 (1989-08-01), None
patent: 0332865 (1989-09-01), None
patent: 1 393 750 (1993-04-01), None
patent: WO 83/04313 (1983-12-01), None
patent: WO 88/03565 (1988-05-01), None
patent: WO 89/01629 (1989-02-01), None
patent: WO 89/07601 (1989-08-01), None
patent: WO 90/06758 (1990-06-01), None
patent: WO 91/04055 (1990-09-01), None
patent: WO 91/02252 (1991-02-01), None
patent: WO 91/16069 (1991-10-01), None
patent: WO 92/14493 (1992-09-01), None
patent: WO 93/13805 (1993-07-01), None
patent: WO 94/10202 (1994-05-01), None
Herbert et al, Dictionary of Immunology, Blackwell Scientific Publications, 1985. pp. 77, 88.
Kabat, Structural Concepts in Immuology and Immunochemistry, Holt, Reinhart and Winston, Inc., 1968, p. 164.
Barrett, Textbook of Immunology, The C.V. Mosby Company, 1978, p. 414.
Clark et al, Proc. Natl. Acad. Sci. USA, 82, 1766-1770, 1985.
Hood et al, Immunology, Second Edition, The Benjamin/Cummings Publishing Company, Inc., 1984, p. 437.
Stashenko et al, Jour. Immunology, 125, 1678-1685, 1980.
Battelli et al., “T lymphocyte killing by a xanthine-oxidase-containing immunotoxin”Cancer Immunol Immunother(1992) 35:421-425.
Blumhardt et al., “Current Clinical Management of Organoprotection in Hepatic Surgery”Klin Wochenschr(1986) (Suppl VII): 144-145.
Budd, “Amifostine: potential for clinically useful cytoprotection”Supprt Care Cancer(1994) 2 (6):380-384.
Bursch et al., “Cytoprotective Effect of the Prostacyclin Derivative Iloprost Against Liver Cell Death Induced by the Hepatotoxins Carbon Tetrachloride and Bromobenzene”Klin Wochenschrift(1986) 64 (Suppl VII) 47-50.
Byczkowska et al., “Two New Monoclonal Antibodies, EPB-1 and EPB-2, Reactive with Human Lymphoma”Cancer Research 4568-4576, Aug. 15, 1989.
Byers et al., “Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain—monoclonal antibody 791T/36 conjugates”Cancer ResOct. 1, 1987:47 (19):5042-5046.
Coleman et al., “Radiation and Chemotherapy Sensitizers and Protectors” Chpt. 18, Cancer Chemotherapy, pp. 424-448.
Chatal et al., “Immunoscintigraphy of Colon Carcinoma”The Journal of Nuclear of Medicine 25: 307-314, 1984.
Curtet et al., “Gd-25 DTPA-Mab, A Potential NMR Contrast Agent for MRI in the Xenografted Nude Mouse: Preliminary Studies”Int. J. Cancer: Supplement 2, 126-132 (1988).
Deland et al., “Lymphoscintigraphy with Radionuclide-labeled Antibodies to Carcinoembryonic Antigen”Cancer Research 40, 2997-3000, Aug. 1980.
Domschke et al., “Antacid Protection of Gastric Mucosa”Klin Wochenschr(1986) 64 (Suppl VII): 28-31.
Ege, “Radiocolloid Lymphoscintigraphy in the Management of Breast Carcinoma”Contemporary Surgeryvol. 20 Feb. 1982.
Ege, “Augmented Iliopelvic Lymphoscintigraphy: Application in the Management of Genitourinary Malignancy”The Journal of Urologyvol. 127 February.
Farber, “Biochemical Mechanisms of Toxic Cell Injury”,Klin Wochenschr(1986) 64 (Suppl VII) 142-143.
Faulstich et al., “New Aspect of Phalloidin Poisoning”,Klin Wochenschr(1986) 64 (Suppl VII): 66-70.
Fishwild et al., “Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-Cell leukemia”Cancer Res. Jun 1, 1992: 52(11): 3056-3062.
Foon et al., “Surface Markers on Leukemia and Lymphoma Cells: Recent advances”Blood, vol. 60 No. 1 (July), 1982.
Galle, “Clinical Presentation and Diagnosis of Endometriosis”,Obstetrics and Gynecology Clinic of North America-vol. 16, No. 1 Mar. 1989 29-41.
Garbrecht et al., “Verapamil in the Prevention of Adriamycin-Induced Cardiomyopathy”Klin Wochenschr(1986) 64 (Suppl VII): 132-134.
Geiger, “Clinical Aspects of Fluid Transport and Vascular Permeability in the Lung”,Klin Wochenschr(1986) 64 (Suppl VII): 18-23.
Goodwin et al., “Chelate Conjugates of Monoclonal Antibodies for Imaging Lymphoid Structures in the Mouse”,J Nucl Med 26:493-503 1985.
Goldenberg et al., “Antigens Associated with Normal and Malignant Gastrointestinal Tissues”Cancer Research 36, 3455-3463, Sep. 1976.
Heene et al., “Shock-Induced Alterations in Hemostasis”Klin Wochenschr(1986) 64 (Suppl VII): 14-17.
Hesch et al., “Metabolism of the Thyroid Hormones with Respect to Cytoprotection”Klin Wochenschr(1986) 64 (Suppl VII): 149-154.
Hill et al., “Predicting Nodal Metastases in Breast Cancer by Lymphoscintigraphy”The Canadian Journal of Surgeryvol. 26 No. 6 Nov. 1983 507-509.
Hnatowich et al., “Investigations of Avidin and Biotin for Imaging Applications”The Journal of Nuclear Medicine 28:1294-1302, 1987.
Hörmann, “Fibronectin Cell Interaction”,Klin Wochenschr(1986) 64 (Suppl VII): 51-53.
Hsu et al., “Phenotypic Expression, of B-Lymphocytes”Am. J. Pathnol; 114 387-395 (1984).
Hsu et al., “Utility of Monoclonal Antibodies Directed Against B and T Lymphocytes and Monocytes in Parraffin-embedded Sections”Am. J. Clin Pathol., 80, 415-420 (1983).
Ingelfinger, “Dorland's Medical Dictionary” pp. 350 & 450.
Jenkins et al., “The Effects of Somatostatin and SMS 201-995 on Expreimentally-Induced Pancreatitis and Endotoxaemia in Rats and on Monocyte Activity in Patients with Cirrhosis and Portal Hypertension”Klin Woc
Immunomedics Inc.
Rossi Kimms & McDowell LLP
Saunders David A
LandOfFree
Method of affecting a function of or ablating a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of affecting a function of or ablating a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of affecting a function of or ablating a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177896